Mayara Mattos

1.6k total citations · 1 hit paper
8 papers, 480 citations indexed

About

Mayara Mattos is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mayara Mattos has authored 8 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mayara Mattos's work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Mosquito-borne diseases and control (2 papers). Mayara Mattos is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Mosquito-borne diseases and control (2 papers). Mayara Mattos collaborates with scholars based in Brazil, Indonesia and Argentina. Mayara Mattos's co-authors include Carolina Q. Sacramento, Thiago Moreno L. Souza, Patrı́cia T. Bozza, André C. Ferreira, Natalia Fintelman‐Rodrigues, Fernando A. Bozza, Jairo R. Temerozo, Vinícius Cardoso Soares, Suelen da Silva Gomes Dias and Caroline S. de Freitas and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Leukocyte Biology.

In The Last Decade

Mayara Mattos

8 papers receiving 477 citations

Hit Papers

SARS-CoV-2 engages inflammasome and pyroptosis in human p... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayara Mattos Brazil 8 290 174 84 80 79 8 480
André C. Ferreira Brazil 11 297 1.0× 194 1.1× 114 1.4× 84 1.1× 80 1.0× 19 584
Caroline S. de Freitas Brazil 11 255 0.9× 203 1.2× 90 1.1× 67 0.8× 79 1.0× 12 520
Takao Sanaki Japan 14 429 1.5× 168 1.0× 59 0.7× 70 0.9× 78 1.0× 27 720
Kirstin Mösbauer Germany 5 397 1.4× 197 1.1× 78 0.9× 72 0.9× 75 0.9× 5 681
Natalia Fintelman‐Rodrigues Brazil 17 362 1.2× 355 2.0× 110 1.3× 115 1.4× 93 1.2× 35 853
Soo Young Byun South Korea 8 348 1.2× 161 0.9× 57 0.7× 123 1.5× 51 0.6× 8 593
Soonju Park South Korea 8 377 1.3× 121 0.7× 50 0.6× 116 1.4× 51 0.6× 10 573
Qingxing Wang China 5 306 1.1× 165 0.9× 45 0.5× 142 1.8× 44 0.6× 8 540
Shaofeng Zhan China 12 120 0.4× 136 0.8× 76 0.9× 40 0.5× 44 0.6× 40 455
Xinghua Li China 11 385 1.3× 130 0.7× 28 0.3× 32 0.4× 148 1.9× 19 613

Countries citing papers authored by Mayara Mattos

Since Specialization
Citations

This map shows the geographic impact of Mayara Mattos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayara Mattos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayara Mattos more than expected).

Fields of papers citing papers by Mayara Mattos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayara Mattos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayara Mattos. The network helps show where Mayara Mattos may publish in the future.

Co-authorship network of co-authors of Mayara Mattos

This figure shows the co-authorship network connecting the top 25 collaborators of Mayara Mattos. A scholar is included among the top collaborators of Mayara Mattos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayara Mattos. Mayara Mattos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ferreira, André C., Carolina Q. Sacramento, Filipe S. Pereira‐Dutra, et al.. (2023). Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages. Frontiers in Cellular and Infection Microbiology. 13. 1067285–1067285. 14 indexed citations
2.
Temerozo, Jairo R., Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, et al.. (2022). VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells. Journal of Leukocyte Biology. 111(5). 1107–1121. 15 indexed citations
3.
Chaves, Otávio Augusto, Natalia Fintelman‐Rodrigues, Xuanting Wang, et al.. (2022). Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones. Viruses. 14(7). 1458–1458. 37 indexed citations
4.
Ferreira, André C., Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, et al.. (2021). SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discovery. 7(1). 43–43. 197 indexed citations breakdown →
5.
Ferreira, André C., Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, et al.. (2021). Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discovery. 7(1). 116–116. 15 indexed citations
6.
Chaves, Otávio Augusto, Carolina Q. Sacramento, André C. Ferreira, et al.. (2021). Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo. Pharmaceuticals. 15(1). 21–21. 29 indexed citations
7.
Fintelman‐Rodrigues, Natalia, Carolina Q. Sacramento, Franklin Souza‐Silva, et al.. (2020). Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Antimicrobial Agents and Chemotherapy. 64(10). 100 indexed citations
8.
Ferreira, André C., Camila Zaverucha-do-Valle, Patrícia A. Reis, et al.. (2017). Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae. Scientific Reports. 7(1). 9409–9409. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026